GILEAD SCIENCES, INC. — Director's Dealing 2015

Oct 27, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-10-26

Reporting Person: Alton Gregg H (EVP, Corp & Med Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-26	Common Stock	M	5000	$24.295	Acquired	138422	Direct
2015-10-26	Common Stock	S	5000	$110.00	Disposed	133422	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-26	Non-Qualified Stock Option (right to buy)	$24.295	M	5000	Disposed	2022-01-26	Common Stock (5000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.